Literature DB >> 17142336

Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43.

Kerstin Boengler1, Ina Konietzka, Astrid Buechert, Yvonne Heinen, David Garcia-Dorado, Gerd Heusch, Rainer Schulz.   

Abstract

Connexin 43 (Cx43) is localized at left ventricular (LV) gap junctions and in cardiomyocyte mitochondria. A genetically induced reduction of Cx43 as well as blockade of mitochondrial Cx43 import abolishes the infarct size (IS) reduction by ischemic preconditioning (IP). With progressing age, Cx43 content in ventricular and atrial tissue homogenates is reduced. We now investigated whether or not 1) the mitochondrial Cx43 content is reduced in aged mice hearts and 2) IS reduction by IP is lost in aged mice hearts in vivo. Confirming previous results, sarcolemmal Cx43 content was reduced in aged (>13 mo) compared with young (<3 mo) C57Bl/6 mice hearts, whereas the expression levels of protein kinase C epsilon and endothelial nitric oxide synthase remained unchanged. Also in mitochondria isolated from aged mice LV myocardium, Western blot analysis indicated a 40% decrease in Cx43 content compared with mitochondria isolated from young mice hearts. In young mice hearts, IP by one cycle of 10 min ischemia and 10 min reperfusion reduced IS (% of area at risk) following 30 min regional ischemia and 120 min reperfusion from 67.7 +/- 3.3 (n = 17) to 34.2 +/- 6.6 (n = 5, P < 0.05). In contrast, IP's cardioprotection was lost in aged mice hearts, since IS in nonpreconditioned (57.5 +/- 4.0, n = 10) and preconditioned hearts (65.4 +/- 6.3, n = 8, P = not significant) was not different. In conclusion, mitochondrial Cx43 content is decreased in aged mouse hearts. The reduced levels of Cx43 may contribute to the age-related loss of cardioprotection by IP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142336     DOI: 10.1152/ajpheart.01071.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  59 in total

Review 1.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

2.  Age-associated differences in gene expression in response to delayed anesthetic preconditioning.

Authors:  C Zhong; N Fleming; X Lu; P Moore; H Liu
Journal:  Age (Dordr)       Date:  2011-10-19

3.  Middle age aggravates myocardial ischemia through surprising upholding of complex II activity, oxidative stress, and reduced coronary perfusion.

Authors:  Evangelia Mourmoura; Marie Leguen; Hervé Dubouchaud; Karine Couturier; Damien Vitiello; Jean-Luc Lafond; Melanie Richardson; Xavier Leverve; Luc Demaison
Journal:  Age (Dordr)       Date:  2010-09-29

Review 4.  The late phase of preconditioning and its natural clinical application--gene therapy.

Authors:  Roberto Bolli; Qian-Hong Li; Xian-Liang Tang; Yiru Guo; Yu-Ting Xuan; Gregg Rokosh; Buddhadeb Dawn
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 5.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 6.  Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3.

Authors:  Karol Szczepanek; Qun Chen; Andrew C Larner; Edward J Lesnefsky
Journal:  Mitochondrion       Date:  2011-09-10       Impact factor: 4.160

7.  Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy.

Authors:  Asli F Ceylan-Isik; Maolong Dong; Yingmei Zhang; Feng Dong; Subat Turdi; Sreejayan Nair; Masashi Yanagisawa; Jun Ren
Journal:  Basic Res Cardiol       Date:  2013-02-05       Impact factor: 17.165

8.  Hypoxia-regulated activity of PKCepsilon in the lens.

Authors:  Vladimir Akoyev; Satyabrata Das; Snehalata Jena; Laura Grauer; Dolores J Takemoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-07       Impact factor: 4.799

9.  Cardioprotection and ageing.

Authors:  Yon Hee Shim
Journal:  Korean J Anesthesiol       Date:  2010-03-30

10.  Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.

Authors:  Kerstin Boengler; Denise Hilfiker-Kleiner; Gerd Heusch; Rainer Schulz
Journal:  Basic Res Cardiol       Date:  2010-10-20       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.